Latest Biologic Stories
TNF-Alpha Inhibitors--Including Sales Leader Humira--Accounted for Over 90 Percent of the Psoriatic Arthritis Market, According to Findings from Decision Resources Group BURLINGTON, Mass.,
SHM-XEL Platform Successfully Generates Novel Therapeutic Approach to Autoimmune Disease SAN DIEGO, Sept.
-- SYN-005 Neutralizing Antibody Combination Protects Against Pertussis in Murine and Non-Human Primate Models -- ROCKVILLE, Md., Sept.
BEIJING, Sept. 5, 2014 /PRNewswire/ -- China Biologic Products, Inc.
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced the appointment
BEIJING, Sept. 4, 2014 /PRNewswire/ -- China Biologic Products, Inc.
SEATTLE and VANCOUVER, British Columbia, Sept.
Experienced Financial and Operational Leader to Support Global Development of Novel Monoclonal Antibody Therapeutics to GPCRs LA JOLLA, Calif. and SHANGHAI, Sept.
ROCKVILLE, Md., Sept.
SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Ajinomoto Althea, Inc.
- In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.